ARCHIVES

Bush Limits Drug Company Efforts To Block Generics

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Kington Named Acting NIH Director.

November 14, 2008

Idaho Senator Pressure DeVita On Taking Neutron Facility

May 6, 1988

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

NCI to hold 5 percent of division budgets in reserve for “strategic priorities.” Competing RPG budgets to be cut 18 percent on average.

February 13, 2004

ASCO to form commission to study tobacco problem.

January 23, 2004